Source: International Congress 2019 – Advances in asthma pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Allinne (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), S. Asrat (Tarrytown, United States of America), K. Nagashima (Tarrytown, United States of America), A. Le Floc'H (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), G. Yancopoulos (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America). Broader Impact of IL-4Ra Blockade Than IL-5 Blockade on Type 2 Inflammation. 3877

Member's Comments

No comment yet.

Related content which might interest you: Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case–Control Study of Women Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha Source: International Congress 2018 – Basic pharmacology Year: 2018 Upregulation of Suppressors of Cytokine Signalling (SOCS)3 in COPD alveolar macrophages. Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Clinical Evidence for Targeted Strategies in Asthma with Type 2 Inflammation: Single and Dual Inhibition Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics Year: 2017 Modulation of Transient Receptor Potential Vanilloid-1 (TRPV1) response by inhaled prostaglandin-E2 and bradykinin Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction Year: 2018 Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 TLR2 Promotes Allergic Airway Inflammation through JNK signaling pathway with Activation of Autophagy Source: International Congress 2017 – Infection and exacerbation science Year: 2017 RAGE Partially Mediates Cigarettes Smoke Extract induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cAMP in human macrophages Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Blockade of TSLP pathway alters asthma biomarkers Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Maintenance of IRF1 by MAPK inhibition: A mechanism by which DUSP1 reduces glucocorticoid inhibition of CXCL10 Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 The Effect of Cordycepin and Simvastatin on Cigarettes Smoke Extract Induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Nrf2-dependent and -independent cytoprotective actions of the electrophilic Cox-2-derived 17-oxo-DHA in human macrophages Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Biology and Role of Type 2 Airway Inflammation Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics Year: 2017 The effect of budesonide on TLR expression in alveolar macrophages from smokers Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Late Breaking Abstract: IL-17 inhibits IL-23 release during airway inflammation Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010